Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$334,753
+$92,339 QoQ
Shares Held
2,136
+34.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,070
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NIXON PEABODY TRUST CO holds $47,887,604 across 9 Drug Manufacturers - General names. NVS ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,298 | $19,548,311 | |
| 2 | MRK |
Merck & Co., Inc.
|
77,974 | $10,019,659 | |
| 3 | AZN |
Astrazeneca PLC
|
42,186 | $7,999,309 | |
| 4 | JNJ |
Johnson & Johnson
|
22,335 | $5,672,419 | |
| 5 | ABBV |
AbbVie Inc.
|
8,249 | $2,075,778 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,564 | $1,460,995 | |
| 7 | AMGN |
Amgen Inc
|
1,381 | $500,087 | |
| 8 | NVS |
Novartis AG
This page
|
2,136 | $334,753 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334,753 | 2,136 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $242,414 | 1,587 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $262,228 | 1,902 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $340,092 | 2,652 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $780,393 | 6,449 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $874,226 | 7,842 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $4,135,772 | 42,501 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $14,005,985 | 121,770 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $12,825,874 | 120,476 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $12,119,108 | 125,288 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $12,243,319 | 121,257 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,969,157 | 19,332 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,005,788 | 19,877 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,302,208 | 25,024 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,951,115 | 21,507 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,639,307 | 21,567 | Shares | Sole | 2023-03-15 | |
| 2022-06-30 | $3,019,073 | 35,716 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,017,721 | 45,786 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,522,024 | 51,698 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,939,342 | 48,170 | Shares | Other | 2021-11-04 | |
| 2021-06-30 | $4,223,772 | 46,293 | Shares | Other | 2021-07-30 | |
| 2021-03-31 | $3,758,127 | 43,965 | Shares | Other | 2021-04-26 | |
| 2020-12-31 | $4,146,609 | 43,912 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $3,854,588 | 44,326 | Shares | Other | 2020-11-03 | |
| 2020-06-30 | $3,824,268 | 43,786 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $3,558,789 | 43,163 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||